Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

NCT03267498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Nivolumab
DRUG: Cisplatin
RADIATION: Radiation Therapy

Sponsor

Sue Yom

Collaborators

[object Object]
[object Object]